Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3513 Target Snapshot

Acidic alpha-glucosidase · SINGLE PROTEIN · Rattus norvegicus

396Compounds
92Assays
6Approved Drugs
395.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q6P7A9. Use UniProt Q6P7A9 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q6P7A9 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Acidic alpha-glucosidase as ChEMBL target CHEMBL3513, mapped to UniProt Q6P7A9. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Acidic alpha-glucosidase
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL3513
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q6P7A9
Lysosomal alpha-glucosidase
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Acidic alpha-glucosidase is the right protein anchor across sources, using UniProt Q6P7A9 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelLysosomal alpha-glucosidase
UniProt AccessionQ6P7A9
Component TypeProtein
Sequence Length953 aa

Lysosomal alpha-glucosidase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Acidic alpha-glucosidase, mapped to UniProt Q6P7A9. ChEMBL maps the protein component as Lysosomal alpha-glucosidase. Sequence length is 953 aa.

Mapped IDQ6P7A9
Review nameAcidic alpha-glucosidase
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

6
Approved
1
Phase III
1
Phase II
1
Phase I
Assay Mix

Activity Type Distribution

IC50374.0
KI21.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL2442258 7.7 IC50 20.0 Preclinical
CHEMBL501355 7.1 IC50 80.0 Preclinical
CHEMBL1641739 7.07 Ki 85.0 Preclinical
CHEMBL3311516 6.96 IC50 110.0 Preclinical
CHEMBL460255 6.96 Ki 110.0 Preclinical
CHEMBL476960 6.96 IC50 110.0 Approved
CHEMBL1641739 6.89 IC50 130.0 Preclinical
CHEMBL307429 6.89 IC50 130.0 Clinical
CHEMBL404271 6.8 IC50 160.0 Approved
CHEMBL3311517 6.77 IC50 170.0 Preclinical
Distribution

pChEMBL Value Distribution

46
5.0
43
5.5
36
6.0
32
6.5
2
7.0
1
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

MIGLITOL
CHEMBL1561
Approved 1996
ACARBOSE
CHEMBL404271
Approved 1995
VOGLIBOSE
CHEMBL476960
Approved 1994
Assay Landscape

Assay Landscape

92
Total Assays
240
Tested Compounds
1
Assay Types
Binding — 92 assays, 240 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 65 181 5.5
assay format 16 29 5.6
cell membrane format 6 16 5.8
tissue-based format 5 14 5.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine